Molecular Templates Q1 2024 GAAP EPS $0.08 Beats $(0.78) Estimate, Sales $11.09M Beat $5.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Molecular Templates (NASDAQ:MTEM) reported Q1 2024 GAAP EPS of $0.08, significantly beating the analyst estimate of $(0.78). The company also reported sales of $11.09 million, surpassing the $5.90 million estimate. However, this represents a 69.73% decrease from the same period last year.
May 15, 2024 | 9:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Molecular Templates reported a strong Q1 2024 with GAAP EPS of $0.08, beating estimates by 110.26%. Sales of $11.09 million also exceeded expectations but were down 69.73% year-over-year.
The significant beat on both EPS and sales estimates is likely to have a positive short-term impact on MTEM's stock price. However, the year-over-year decline in sales may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100